01PEPTIDE
Ipamorelin
A selective ghrelin-receptor agonist studied as a growth hormone secretagogue, with limited modern human clinical evidence.
NeuroendocrineBody CompositionRecovery
EXPLORE THIS GOAL · PB
Performance + Body Composition
Endurance, recovery and lean-mass research. Use this dashboard to move between records, protocols, comparisons, research and tools.
01
Relevant peptides
02PEPTIDE
CJC-1295
A long-acting growth hormone-releasing hormone analogue studied in healthy adults for GH and IGF-1 pharmacodynamics.
NeuroendocrineBody CompositionRecovery
03PEPTIDE
Sermorelin
A GHRH(1-29) analogue formerly approved for pediatric diagnostic and treatment contexts and later discontinued commercially.
NeuroendocrineBody CompositionRecovery
04PEPTIDE
BPC-157
A gastric-derived research peptide studied primarily in preclinical tissue-repair and gastrointestinal models.
RecoveryGutSoft Tissue
05PEPTIDE
Retatrutide
An investigational GIP, GLP-1 and glucagon receptor agonist studied for obesity and metabolic outcomes.
Weight ManagementAppetiteGlucose / Insulin
06PEPTIDE
MOTS-C
A mitochondrial-derived peptide studied in metabolic signaling, cellular stress and exercise models.
Mitochondrial HealthEnergyMetabolic
07PEPTIDE
Tirzepatide
An approved dual GIP and GLP-1 receptor agonist studied across type 2 diabetes, obesity and cardiometabolic outcomes.
Weight ManagementAppetiteGlucose / Insulin
08PEPTIDE
Semaglutide
An approved GLP-1 receptor agonist with formulation- and indication-specific evidence for diabetes, weight management and cardiovascular outcomes.
Weight ManagementAppetiteGlucose / Insulin
09PEPTIDE
Cagrilintide
An investigational long-acting amylin analogue studied alone and with semaglutide for weight management.
Weight ManagementAppetiteFat Loss
10PEPTIDE
CagriSema
An investigational fixed combination of cagrilintide and semaglutide studied in metabolic and weight-management trials.
Weight ManagementAppetiteGlucose / Insulin
11PEPTIDE
Tesamorelin
A GHRF analogue approved for reduction of excess abdominal fat in adults with HIV and lipodystrophy, with additional research contexts.
Body CompositionFat LossNeuroendocrine
12PEPTIDE
AOD-9604
A modified growth-hormone fragment studied in metabolic and obesity research, with limited supportive clinical efficacy data.
Fat LossWeight ManagementBody Composition
13PEPTIDE
5-Amino-1MQ
A small-molecule NNMT inhibitor studied primarily in preclinical metabolic and adipose-tissue models.
Fat LossBody CompositionMetabolic
14PEPTIDE
Survodutide
An investigational GLP-1 and glucagon receptor dual agonist in clinical development for obesity and metabolic liver disease.
Weight ManagementAppetiteFat Loss
15PEPTIDE
Mazdutide
A GLP-1 and glucagon receptor dual agonist studied in obesity and type 2 diabetes, with development and regulatory status varying by region.
Weight ManagementGlucose / InsulinFat Loss
16PEPTIDE
Pemvidutide
An investigational GLP-1 and glucagon receptor dual agonist studied for obesity and metabolic liver disease.
Weight ManagementFat LossBody Composition
17PEPTIDE
TB-500
A synthetic N-acetylated fragment associated with thymosin beta-4 research and anti-doping analysis.
RecoverySoft TissueWound Repair
02
Related protocols
03
Popular comparisons
04
Related research
SPONSOR UPDATETRIUMPH-1 Phase 3 topline resultsRetatrutide · Eli Lilly and Company · 2026SPONSOR UPDATETRIUMPH-2 and TRIUMPH-3 Phase 3 topline results and planned regulatory submissionRetatrutide · Eli Lilly and Company · 2026REGULATORYWhat to know about retatrutideRetatrutide · Eli Lilly and Company · 2026HUMANSafety of Intravenous Infusion of BPC157 in HumansBPC-157 · Journal of Clinical Medicine · 2025CLINICAL TRIALCoadministered Cagrilintide and Semaglutide in Adults with Overweight or ObesityCagriSema · New England Journal of Medicine · 2025CLINICAL TRIALTriple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver diseaseRetatrutide · Nature Medicine · 2024
05
Tools
06
Related goals
BUILD FROM THIS RESEARCH CONTEXT
Build a stack for Performance + Body Composition
The goal stays visible in the stack builder. Related records are suggestions by tag overlap; you choose what to add.